PAR •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 17:36
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization13.66 mln
Float8.88 mln
Earnings Date03/27/2025
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-6.43
Highly reliable
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
-0.72
Negative equity
Pre-Tax Margin
-165%
Severely loss-making
Dividend Yield
0.00%
No dividend
Business Description
Advicenne S.A. is a French pharmaceutical company founded in 2007 and based in Paris, focused on developing and selling medicines for rare kidney conditions across France and global markets. Its primary product, Sibnayal, treats two uncommon kidney disorders, while its broader portfolio includes treatments for anxiety and epileptic seizures. The company serves patients with serious and often underserved medical needs.
